Optimization of Prime-Boost Vaccination Strategies Against Mouse-Adapted Ebolavirus in a Short-Term Protection Study (Q40153269)

18 September 2017

title

Optimization of Prime-Boost Vaccination Strategies Against Mouse-Adapted Ebolavirus in a Short-Term Protection Study (English)

1 reference

18 September 2017

3

Gary Wong

1 reference

18 September 2017

6

Gary Kobinger

1 reference

18 September 2017

5

Xiangguo Qiu

1 reference

18 September 2017

Hugues Fausther-Bovendo

series ordinal

4

object named as

Hugues Fausther-Bovendo

1 reference

18 September 2017

Jenna Aviles

1

1 reference

18 September 2017

Alexander Bello

series ordinal

2

1 reference

18 September 2017

language of work or name

English

0 references

publication date

2 June 2015

1 reference

Journal of Infectious Diseases

18 September 2017

published in

1 reference

18 September 2017

volume

212 Suppl 2

1 reference

18 September 2017

page(s)

S389-97

1 reference

18 September 2017

cites work

Ebola haemorrhagic fever

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

Recent advances in Ebolavirus vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

Protection of nonhuman primates against two species of Ebola virus infection with a single complex adenovirus vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

Successful topical respiratory tract immunization of primates against Ebola virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

Antibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with rabies virus based bivalent vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

Durability of a vesicular stomatitis virus-based marburg virus vaccine in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

Development of a preventive vaccine for Ebola virus infection in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

Strategies to overcome host immunity to adenovirus vectors in vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

Development of chimpanzee adenoviruses as vaccine vectors: challenges and successes emerging from clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

A single sublingual dose of an adenovirus-based vaccine protects against lethal Ebola challenge in mice and guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

Airway delivery of an adenovirus-based Ebola virus vaccine bypasses existing immunity to homologous adenovirus in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

Overcoming immunity to a viral vaccine by DNA priming before vector boosting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

Recombinant Modified Vaccinia Ankara (MVA) effectively boosts DNA-primed HIV-specific immune responses in humans despite pre-existing vaccinia immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

Correlates of protective immunity for Ebola vaccines: implications for regulatory approval by the animal rule

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

Immune parameters correlate with protection against ebola virus infection in rodents and nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

Induction of broad cytotoxic T cells by protective DNA vaccination against Marburg and Ebola

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

Enhanced protection against Ebola virus mediated by an improved adenovirus-based vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

Isolation and evaluation of novel adeno-associated virus sequences from porcine tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

Recombinant vectors based on porcine adeno-associated viral serotypes transduce the murine and pig retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

A multiagent filovirus DNA vaccine delivered by intramuscular electroporation completely protects mice from ebola and Marburg virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

Optimization and qualification of an 8-color intracellular cytokine staining assay for quantifying T cell responses in rhesus macaques for pre-clinical vaccine studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

The role of apoptosis in immune hyporesponsiveness following AAV8 liver gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

The complex and evolving story of T cell activation to AAV vector-encoded transgene products

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIV175

21 January 2018

Identifiers

DOI

10.1093/INFDIS/JIV175

1 reference

18 September 2017

1 reference